Expanded Access Programme of PEGASYS (Peg Interferon Alpha-2a 40KD) in Patients With HBeAg-negative Chronic Hepatitis B
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Expanded access; Therapeutic Use
- Sponsors Roche
- 13 Feb 2013 New trial record